3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Uterine Cervical Neoplasms
18
Prostatic Neoplasms
18
Sarcoma
5
Neoplasms
4
Uterine Neoplasms
2
Rhabdomyosarcoma
2
Rectal Neoplasms
2
Liver Neoplasms
2
Esophageal Neoplasms
2
Breast Neoplasms
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Cervical Dysplasia
1
To Evaluate the Efficacy and Safety of Anlotinib Combined With Concurrent Chemoradiotherapy in the Treatment of Locally Advanced Cervical Cancer
1
Retinoblastoma
1
Prostate Cancer With Intermediate Risk
1
Pancreatic Neoplasms
1
Osteosarcoma
1
Oligodendroglioma
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Metastatic Malignant Female Reproductive System Neoplasm
1
Lung Neoplasms
1
Gliosarcoma
1
Glioblastoma
1
Esophageal Squamous Cell Carcinoma
1
Endometrial Neoplasms
1
Endometrial Endometrioid Adenocarcinoma, Variant With Squamous Differentiation
1
Endometrial Adenocarcinoma
1
Desmoplastic Small Round Cell Tumor
1
Cholangiocarcinoma
1
Interventions
Radiotherapy
1
Brachytherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Prostate Cancer With Intermediate Risk
×
Brachytherapy
×
Clear all
NCT01039038
2011-11-28
CURIEBOOST
Centre Francois Baclesse
Phase 2
Terminated
50 enrolled